{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:28:11Z","timestamp":1781332091313,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,2,5]],"date-time":"2013-02-05T00:00:00Z","timestamp":1360022400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s12328-013-0359-0","type":"journal-article","created":{"date-parts":[[2013,2,4]],"date-time":"2013-02-04T14:43:56Z","timestamp":1359989036000},"page":"139-144","source":"Crossref","is-referenced-by-count":13,"title":["Drug-induced liver injury associated with Agaricus blazei Murill which is very similar to autoimmune hepatitis"],"prefix":"10.1007","volume":"6","author":[{"given":"Akiko","family":"Hisamochi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Kage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruko","family":"Arinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Ide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Miyajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiichiro","family":"Kuwahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriko","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryukichi","family":"Kumashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Sata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,5]]},"reference":[{"key":"359_CR1","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1200\/JCO.2005.04.126","volume":"23","author":"I Hyodo","year":"2005","unstructured":"Hyodo I, Amano N, Eguchi K, Narabayashi M, Imanishi J, Hirai M, et al. Nationwide survey on complementary alternative medicine in cancer patients in Japan. J Clin Oncol. 2005;23:2645\u201354.","journal-title":"J Clin Oncol."},{"key":"359_CR2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3727\/096504005776404580","volume":"15","author":"A Girgis","year":"2005","unstructured":"Girgis A, Adams J, Sibbritt D. The use of complementary and alternative therapies by patients with cancer. Oncol Res. 2005;15:281\u20139.","journal-title":"Oncol Res."},{"key":"359_CR3","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199906033402206","volume":"340","author":"HJ Burstein","year":"1999","unstructured":"Burstein HJ, Gelber S, Guadagnoli E, Weeks JC. Use of alternative medicine by women with early-stage breast cancer. N Engl J Med. 1999;340:1733\u20139.","journal-title":"N Engl J Med."},{"key":"359_CR4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0002-9610(00)00358-5","volume":"179","author":"KT Morris","year":"2000","unstructured":"Morris KT, Johnson N, Homer L, Walts D. A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg. 2000;179:407\u201311.","journal-title":"Am J Surg."},{"key":"359_CR5","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1089\/107555302760253676","volume":"8","author":"RE Patterson","year":"2002","unstructured":"Patterson RE, Neuhouser ML, Hedderson MM, Schwartz SM, Standish LJ, Bowen DJ, et al. Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complement Med. 2002;8:477\u201385.","journal-title":"J Altern Complement Med."},{"key":"359_CR6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0008-6215(89)84040-6","volume":"186","author":"H Kawagishi","year":"1989","unstructured":"Kawagishi H, Inagaki R, Kanao T, Mizuno T, Shimura K, Ito H, et al. Fractionation and antitumor activity of the water-insoluble residue of Agaricus blazei fruiting bodies. Carbohydr Res. 1989;186:267\u201373.","journal-title":"Carbohydr Res."},{"key":"359_CR7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1271\/bbb.62.434","volume":"62","author":"M Mizuno","year":"1998","unstructured":"Mizuno M, Morimoto M, Minato K, Tsuchida H. Polysaccharides from Agaricus blazei stimulate lymphocyte T-cell subsets in mice. Biosci Biotechnol Biochem. 1998;62:434\u20137.","journal-title":"Biosci Biotechnol Biochem"},{"key":"359_CR8","first-page":"17","volume":"1","author":"K Takeda","year":"2004","unstructured":"Takeda K, Okumura K. CAM and NK cells. eCAM. 2004;1:17\u201327.","journal-title":"eCAM."},{"key":"359_CR9","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","volume":"46","author":"G Danan","year":"1993","unstructured":"Danan G, Benichou C. Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of International consensus meetings: application to drug-Induced liver injuries. J Clin Epidemiol. 1993;46:1323\u201330.","journal-title":"J Clin Epidemiol"},{"key":"359_CR10","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929\u201338.","journal-title":"J Hepatol"},{"key":"359_CR11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","volume":"48","author":"EM Hennes","year":"2008","unstructured":"Hennes EM, Zeniya M, Czaja AJ, Par\u00e9s A, Dalekos GN, Krawitt EL, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169\u201376.","journal-title":"Hepatology"},{"key":"359_CR12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3322\/canjclin.42.3.181","volume":"42","author":"IJ Lerner","year":"1992","unstructured":"Lerner IJ, Kennedy BJ. The prevalence of questionable methods of cancer treatment in the United States. CA Cancer J Clin. 1992;42:181\u201391.","journal-title":"CA Cancer J Clin"},{"key":"359_CR13","first-page":"149","volume":"7","author":"JM Metz","year":"2001","unstructured":"Metz JM, Jones H, Devine P, Hahn S, Glastein E. Cancer patients use unconventional medical therapies far more frequently than standard history and physical examination suggest. Cancer J. 2001;7:149\u201354.","journal-title":"Cancer J"},{"key":"359_CR14","first-page":"179","volume":"90","author":"H Wanmuanq","year":"2007","unstructured":"Wanmuanq H, Leopairut J, Kositchaiwat C, Wananukul W, Bunyaratvej S. Fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder. J Med Assoc Thai. 2007;90:179\u201381.","journal-title":"J Med Assoc Thai"},{"key":"359_CR15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00004836-200207000-00016","volume":"35","author":"J Kogan","year":"2002","unstructured":"Kogan J, Safadi R, Ashur Y, Shouval D, Ilan Y. Prognosis of symptomatic versus asymptomatic autoimmune Hepatitis, a study of 68 patients. J Clin Gastroenterol. 2002;35:75\u201381.","journal-title":"J Clin Gastroenterol"},{"key":"359_CR16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/hep.1840030510","volume":"3","author":"JE Hegarty","year":"1983","unstructured":"Hegarty JE, Nouri Aria KT, Portmann B, Eddleston AL, Williams R. Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis. Hepatology. 1983;3:685\u20139.","journal-title":"Hepatology"},{"key":"359_CR17","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/0016-5085(80)90866-5","volume":"78","author":"AJ Czaja","year":"1980","unstructured":"Czaja AJ, Ammon HV, Summerskill WH. Clinical features and prognosis of severe chronic active liver disease (CALD) after corticosteroid-induced remission. Gastroenterology. 1980;78:518\u201323.","journal-title":"Gastroenterology"},{"key":"359_CR18","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1749-6632.1965.tb19000.x","volume":"124","author":"IR Mackay","year":"1965","unstructured":"Mackay IR, Weiden S, Hasker J. Autoimmune hepatitis. Ann NY Acad Sc. 1965;124:767\u201380.","journal-title":"Ann NY Acad Sc."},{"key":"359_CR19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1247\/csf.15.317","volume":"15","author":"K Sorimachi","year":"1990","unstructured":"Sorimachi K, Akimoto K, Yamazaki S, Niwa A, Toda S, Yasumura Y. Multinucleation of macrophages with water-solubilized lignin derivatives in vitro. Cell Struct Funct. 1990;15:317\u201322.","journal-title":"Cell Struct Funct"},{"key":"359_CR20","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0168-8278(97)80453-9","volume":"26","author":"G Toda","year":"1997","unstructured":"Toda G, Zeniya M, Watanabe F, Imawari M, Kiyosawa K, Nishioka M, et al. Present status of autoimmune hepatitis in Japan-correlating the characteristics with international criteria in an area with high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis. J Hepatol. 1997;26:1207\u201312.","journal-title":"J Hepatol"},{"key":"359_CR21","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI115443","volume":"88","author":"MP Manns","year":"1991","unstructured":"Manns MP, Griffin KJ, Sullivan KF, Johnson EF. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J Clin Invest. 1991;88:1370\u20138.","journal-title":"J Clin Invest."},{"key":"359_CR22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1872-034X.2008.00486.x","volume":"39","author":"H Takikawa","year":"2009","unstructured":"Takikawa H, Murata Y, Horiike N, Fukui H, Onji M. Drug-induced liver injury in Japan: an analysis of 1676 cases between 1997 and 2006. Hepatol Res. 2009;39:427\u201331.","journal-title":"Hepatol Res."},{"key":"359_CR23","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/jjco\/hyl108","volume":"36","author":"H Mukai","year":"2006","unstructured":"Mukai H, Watanabe T, Ando M, Katsumata N. An alternative medicine, Agaricus blazei, may have induced severe hepatic dysfunction in cancer patients. Jpn J Clin Oncol. 2006;36:808\u201310.","journal-title":"Jpn J Clin Oncol"},{"key":"359_CR24","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2957\/kanzo.46.142","volume":"46","author":"M Onji","year":"2005","unstructured":"Onji M, Takikawa H, Murata Y, Hashimoto N, Kojima Y, Hisamochi A, et al. Surveillance of folk medicine-induced hepatitis. Kanzo. 2005;46:142\u20138. (in Japanese).","journal-title":"Kanzo."},{"key":"359_CR25","doi-asserted-by":"crossref","first-page":"442","DOI":"10.5694\/j.1326-5377.2003.tb05286.x","volume":"178","author":"PJ Gow","year":"2003","unstructured":"Gow PJ, Connelly NJ, Hill RL, Crowley P, Angus PW. Fatal fulminant hepatic failure induced by natural therapy containing kava. Med J Aust. 2003;178:442\u20133.","journal-title":"Med J Aust"},{"key":"359_CR26","unstructured":"National Center for Complementary and Alternative Medicine. Kava Linked to Liver Damage. [Cited 30 Oct 2012]. Available from URL: http:\/\/nccam.nih.gov\/news\/alerts\/kava\/ ."}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-013-0359-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12328-013-0359-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-013-0359-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T19:19:04Z","timestamp":1595359144000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12328-013-0359-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,5]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["359"],"URL":"https:\/\/doi.org\/10.1007\/s12328-013-0359-0","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,5]]}}}